Compounds and compositions as protein kinase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 9, 2008
Grant Date -
Jul 14, 2005
app pub date -
Apr 30, 2004
filing date -
May 1, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases and disorders associated with kinase activity, particularly diseases associated with the activity of CDK1, CDK2, CDK4, CDK5, GSK3.beta., Bcr-ab1, Flt-3, c-Kit, PDGFR.beta., Src, Mek1 and CK1.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully